Aiming for remission in adults with attention-deficit/hyperactivity disorder: The primary care goal

References

• Biederman J, Faraone SV, Spencer TJ, Mick B, Monuteaux MC, Aleardi M. Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community. J Clin Psychiatry 2006;67:524–40.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716–23.
   PubMed Web of Science ®Google Scholar
• de Graaf R, Kessler RC, Fayyad J, ten Have M, Alonso J, Angermeyer M, et al. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med 2008;65:835–42.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Morrison NR, Prince J. An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert Rev Neurother 2011;11:1443–65.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Glatt SJ. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry 2010;71:754–63.
   PubMed Web of Science ®Google Scholar
• Surman CB, Hammerness PG, Pion K, Faraone SV. Do stimulants improve functioning in adults with ADHD? A review of the literature. Eur Neuropsychopharmacol 2013;23:528–33.
   PubMed Web of Science ®Google Scholar
• Culpepper L, Fried R. Attention-deficit/hyperactivity disorder in a chronic care paradigm. Postgrad Med 2013;125:78–86.
   PubMed Web of Science ®Google Scholar
• Biederman J, Petty CR, Evans M, Small J, Faraone SV. How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Res 2010;177:299–304.
   PubMed Web of Science ®Google Scholar
• Makris N, Biederman J, Valera EM, Bush G, Kaiser J, Kennedy DN, et al. Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder. Cereb Cortex 2007;17:1364–75.
   PubMed Web of Science ®Google Scholar
• Arnsten AF, Berridge CW, McCracken JT. The neurological basis of attention-deficit/hyperactivity disorder. Prim Psychiatry 2009;16:47–54.
   Google Scholar
• Valera EM, Brown A, Biederman J, Faraone SV, Makris N, Monuteaux MC, et al. Sex differences in the functional neuroanatomy of working memory in adults with ADHD. Am J Psychiatry 2010;167:86–94.
   PubMed Web of Science ®Google Scholar
• Semrud-Clikeman M, Pliszka SR, Bledsoe J, Lancaster J. Volumetric MRI differences in treatment naive and chronically treated adolescents with ADHD-combined type. J Atten Disord 2012;18:511–20.
   PubMed Web of Science ®Google Scholar
• Franke B, Neale BM, Faraone SV. Genome-wide association studies in ADHD. Hum Genet 2009;126:13–50.
   PubMed Web of Science ®Google Scholar
• Poelmans G, Pauls DL, Buitelaar JK, Franke B. Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder. Am J Psychiatry 2011;168:365–77.
   PubMed Web of Science ®Google Scholar
• Biederman J, Petty CR, Wilens TE, Fraire MG, Purcell CA, Mick E, et al. Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders. Am J Psychiatry 2008;165:107–15.
   PubMed Web of Science ®Google Scholar
• Durston S, Fossella JA, Mulder MJ, Casey BJ, Ziermans TB, Vessaz MN, et al. Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation. J Am Acad Child Adolesc Psychiatry 2008;47:61–7.
   PubMed Web of Science ®Google Scholar
• Santosh PJ, Sattar S, Canagaratnam M. Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults. CNS Drugs 2011;25:737–63.
   PubMed Web of Science ®Google Scholar
• Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 2002;111:279–89.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Attention-deficit and disruptive behavior disorders. In Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR, 4th edition. Washington, DC: American Psychiatric Association; 2000:85–93.
   Google Scholar
• Barkley RA. Deficient emotional self-regulation: a core component of attention-deficit/hyperactivity disorder. J ADHD Relat Disord 2010;1:5–37.
   Google Scholar
• Biederman J, Petty CR, Fried R, Kaiser R, Doyle AE, Cohen DR, et al. Educational and occupational underattainment in adults with attention-deficit/hyperactivity disorder: a controlled study. J Clin Psychiatry 2008;69:1217–22.
   PubMed Web of Science ®Google Scholar
• Able SL, Johnston JA, Adler LA, Swindle RW. Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol Med 2007;37:97–107.
   PubMed Web of Science ®Google Scholar
• Biederman J, Seidman LJ, Petty CR, Fried R, Doyle AE, Cohen DR, et al. Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2008;69:1150–6.
   PubMed Web of Science ®Google Scholar
• Biederman J, Monuteaux MC, Spencer T, Wilens TE, Faraone SV. Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics 2009;124:71–8.
   PubMed Web of Science ®Google Scholar
• Das D, Cherbuin N, Butterworth P, Anstey KJ, Easteal S. A population-based study of attention deficit/hyperactivity disorder symptoms and associated impairment in middle-aged adults. PLoS ONE 2012;7:e31500.
   PubMed Web of Science ®Google Scholar
• Bussing R, Mason DM, Bell L, Porter P, Garvan C. Adolescent outcomes of childhood attention-deficit/hyperactivity disorder in a diverse community sample. J Am Acad Child Adolesc Psychiatry 2010;49:595–605.
   PubMed Web of Science ®Google Scholar
• McGough JJ, Smalley SL, McCracken JT, Yang M, Del'Homme M, Lynn DE, Loo S. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry 2005;162:1621–7.
   PubMed Web of Science ®Google Scholar
• Cumyn L, French L, Hechtman L. Comorbidity in adults with attention-deficit hyperactivity disorder. Can J Psychiatry 2009;54:673–83.
   PubMed Web of Science ®Google Scholar
• Shaw P, Stringaris A, Nigg J, Leibenluft E. Emotion dysregulation in attention deficit hyperactivity disorder. Am J Psychiatry 2014;171:276–93.
   PubMed Web of Science ®Google Scholar
• Babinski LM, Hartsough CS, Lambert NM. Childhood conduct problems, hyperactivity-impulsivity, and inattention as predictors of adult criminal activity. J Child Psychol Psychiatry 1999;40:347–55.
   PubMed Web of Science ®Google Scholar
• Chronis-Tuscano A, Molina BS, Pelham WE, et al. Very early predictors of adolescent depression and suicide attempts in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2010;67:1044–51.
   PubMed Web of Science ®Google Scholar
• August GJ, Winters KC, Realmuto GM, Fahnhorst T, Botzet A, Lee S. Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants. J Am Acad Child Adolesc Psychiatry 2006;45:824–32.
   PubMed Web of Science ®Google Scholar
• Elkins IJ, McGue M, Iacono WG. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch Gen Psychiatry 2007;64:1145–52.
   PubMed Web of Science ®Google Scholar
• Youngstrom EA, Arnold LE, Frazier TW. Bipolar and ADHD comorbidity: both artifact and outgrowth of shared mechanisms. Clin Psychol (New York) 2010;17:350–9.
   PubMed Web of Science ®Google Scholar
• Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991;48:851–5.
   PubMed Web of Science ®Google Scholar
• Chou WJ, Chen SJ, Chen YS, Liang HY, Lin CC, Tang CS, et al. Remission in children and adolescents diagnosed with attention-deficit/hyperactivity disorder via an effective and tolerable titration scheme for osmotic release oral system methylphenidate. J Child Adolesc Psychopharmacol 2012;22:215–25.
   PubMed Web of Science ®Google Scholar
• Brown TE, Brams M, Gasior M, Adeyi B, Babcock T, Dirks B, et al. Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults. Curr Med Res Opin 2011;27:23–33.
   PubMed Web of Science ®Google Scholar
• Dickson RA, Maki E, Gibbins C, Gutkin SW, Turgay A, Weiss MD. Time courses of improvement and symptom remission in children treated with atomoxetine for attention-deficit/hyperactivity disorder: analysis of Canadian open-label studies. Child Adolesc Psychiatry Ment Health 2011;5:14.
   PubMedGoogle Scholar
• Findling RL, Adeyi B, Chen G, Dirks B, Babcock T, Scheckner B, et al. Clinical response and symptomatic remission in children treated with lisdexamfetamine dimesylate for attention-deficit/hyperactivity disorder. CNS Spectr 2010;15:559–68.
   Web of Science ®Google Scholar
• Mattingly GW, Weisler RH, Young J, Dirks B, Babcock T, Lasser R, et al. Response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. Poster presented at the US Psychiatric and Mental Health Congress Conference and Exhibition, November 2–5, 2009; Las Vegas, NV.
   Google Scholar
• Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, et al. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. Pediatrics 2004;114:e1–8.
   PubMed Web of Science ®Google Scholar
• Ramos-Quiroga JA, Casas M. Achieving remission as a routine goal of pharmacotherapy in attention-deficit hyperactivity disorder. CNS Drugs 2011;25:17–36.
   PubMed Web of Science ®Google Scholar
• Steele M, Jensen PS, Quinn DM. Remission versus response as the goal of therapy in ADHD: a new standard for the field? Clin Ther 2006;28:1892–908.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edition. Washington, DC: American Psychiatric Association; 2013.
   Google Scholar
• Goodman D, Faraone SV, Adler LA, Dirks B, Hamdani M, Weisler R. Interpreting ADHD rating scale scores: linking ADHD rating scale scores and CGI levels in two randomized controlled trials of lisdexamfetamine dimesylate in ADHD. Prim Psychiatry 2010;17:44–52.
   Google Scholar
• Swanson J, Baler RD, Volkow ND. Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress. Neuropsychopharmacology 2011;36:207–26.
   PubMed Web of Science ®Google Scholar
• Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA 2002;288:2469–75.
   PubMed Web of Science ®Google Scholar
• Torrente F, Lopez P, Alvarez Prado D, Kichic R, Cetkovich-Bakmas M, Lischinsky A, Manes F. Dysfunctional cognitions and their emotional, behavioral, and functional correlates in adults with attention deficit hyperactivity disorder (ADHD): is the cognitive-behavioral model valid? J Atten Disord 2012;18:412–24.
   PubMed Web of Science ®Google Scholar
• Conners CK, Erhardt D, Sparrow E. Conners’ Adult ADHD Rating Scales (CAARS) Technical Manual. New York: Multi-Health Systems; 1999.
   Google Scholar
• DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York, NY: Guilford Press; 1998.
   Google Scholar
• Gomez R. Item response theory analyses of adult self-ratings of the ADHD symptoms in the Current Symptoms Scale. Assessment 2011;18:476–86.
   PubMed Web of Science ®Google Scholar
• Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:885–90.
   PubMed Web of Science ®Google Scholar
• Brown TE. Brown attention-deficit hyperactivity disorder scales for adolescents and adults. San Antonio, TX: The Psychological Corporation; 1996.
   Google Scholar
• Roth RM, Isquith PK, Gioia GA. Behavior rating inventory of executive function-adult version (BRIEF-A) professional manual. Lutz, FL: Psychological Assessment Resources; 2005.
   Google Scholar
• Brod M, Johnston J, Able S, Swindle R. Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale (AAQoL): a disease-specific quality-of-life measure. Qual Life Res 2006;15:117–29.
   PubMed Web of Science ®Google Scholar
• Landgraf JM. Monitoring quality of life in adults with ADHD: reliability and validity of a new measure. J Atten Disord 2007;11:351–62.
   PubMedGoogle Scholar
• Epstein JN, Weiss MD. Assessing treatment outcomes in attention-deficit/hyperactivity disorder: a narrative review. Prim Care Companion CNS Disord 2012;14(6) PCC.11r01336.
   PubMedGoogle Scholar
• Endicott J, Nee J. Endicott Work Productivity Scale (EWPS): a new measure to assess treatment effects. Psychopharmacol Bull 1997;33:13–16.
   PubMed Web of Science ®Google Scholar
• Bird HR, Shaffer D, Fisher P, Gould MS, Canino G, Rubio-Stipec M. The Columbia Impairment Scale (CIS): pilot findings on a measure of global impairment for children and adolescents. Int J Methods Psychiatr Res 1993;3:167–76.
   Web of Science ®Google Scholar
• Weiss MD, Gibbins C, Goodman DW, Hodgkins PS, Landgraf JM, Faraone SV. Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder. J Clin Psychiatry 2010;71:381–90.
   PubMed Web of Science ®Google Scholar
• Coghill D. The impact of medications on quality of life in attention-deficit hyperactivity disorder: a systematic review. CNS Drugs 2010;24:843–66.
   PubMed Web of Science ®Google Scholar
• Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 2006;45:192–202.
   PubMed Web of Science ®Google Scholar
• Adler L, Kessler RC, Spencer T; World Health Organization. Adult ADHD Self-Report Scale (ASRS-v1.1) symptom checklist instructions. http://webdoc.nyumc.org/nyumc/files/psych/attachments/psych_adhd_checklist.pdf. Accessed June 28, 2013.
   Google Scholar
• Rostain AL. Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management. Postgrad Med 2008;120:27–38.
   PubMed Web of Science ®Google Scholar
• Panagiotou OA, Contopoulos-Ioannidis DG, Papanikolaou PN, Ntzani EE, Ioannidis JP. Different black box warning labeling for same-class drugs. J Gen Intern Med 2011;26:603–10.
   PubMed Web of Science ®Google Scholar
• Rabiner DL, Anastopoulos AD, Costello EJ, Hoyle RH, McCabe SE, Swartzwelder HS. The misuse and diversion of prescribed ADHD medications by college students. J Atten Disord 2009;13:144–53.
   PubMed Web of Science ®Google Scholar
• Garnier LM, Arria AM, Caldeira KM, Vincent KB, O'Grady KE, Wish ED. Sharing and selling of prescription medications in a college student sample. J Clin Psychiatry 2010;71:262–9.
   PubMed Web of Science ®Google Scholar
• Lee Booksh R, Pella RD, Singh AN, Drew Gouvier W. Ability of college students to simulate ADHD on objective measures of attention. J Atten Disord 2010;13:325–38.
   PubMed Web of Science ®Google Scholar
• Sollman MJ, Ranseen JD, Berry DT. Detection of feigned ADHD in college students. Psychol Assess 2010;22:325–35.
   PubMed Web of Science ®Google Scholar
• Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothenberger A. Non-stimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry 2004;13:I102–16.
   PubMed Web of Science ®Google Scholar
• Gugelmann H, Perrone J, Nelson L. Windmills and pill mills: can PDMPs tilt the prescription drug epidemic? J Med Toxicol 2012;8:378–86.
   PubMedGoogle Scholar
• Safren SA, Otto MW, Sprich S, Winett CL, Wilens TE, Biederman J. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther 2005;43:831–42.
   PubMed Web of Science ®Google Scholar
• Safren SA, Sprich S, Mimiaga MJ, Surman C, Knouse L, Groves M, Otto MW. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA 2010;304:875–80.
   PubMed Web of Science ®Google Scholar
• Solanto MV, Marks DJ, Wasserstein J, Mitchell K, Abikoff H, Alvir JM, Kofman MD. Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry 2010;167:958–68.
   PubMed Web of Science ®Google Scholar
• Knouse LE, Safren SA. Current status of cognitive behavioral therapy for adult attention-deficit hyperactivity disorder. Psychiatr Clin North Am 2010;33:497–509.
   PubMed Web of Science ®Google Scholar
• Mongia M, Hechtman L. Cognitive behavior therapy for adults with attention-deficit/hyperactivity disorder: a review of recent randomized controlled trials. Curr Psychiatry Rep 2012;14:561–7.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716–23.
   PubMed Web of Science ®Google Scholar
• Youngstrom EA, Arnold LE, Frazier TW. Bipolar and ADHD comorbidity: both artifact and outgrowth of shared mechanisms. Clin Psychol (New York) 2010;17:350–9.
   PubMed Web of Science ®Google Scholar